BSE filing, NSE: GROVY. Summary written from the filing by ALFA Finder's alert engine.
Grovy India Ltd: key numbers
- Share price
- ₹65.00
- Market cap
- ₹86.69 Cr
- Revenue (annual)
- ₹33.20 Cr
- Net profit (annual)
- ₹2.90 Cr
- P/E (TTM)
- 16.2×Sector 33.7×
- Promoter holding
- 65.13%-7.87% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Grovy India Ltd
All →Grovy India Legal & Regulatory
ITAT Delhi deleted a ₹1 Crore Section 68 addition for Grovy India for AY 2020-21. The Tribunal partly allowed the company's appeal, reducing tax demand.
- Value
- ₹1.00 Cr
Grovy India Investor Presentation: Key Takeaways
H1 FY27 revenue ₹54.76 Cr (+129.84% YoY), H1 PAT ₹3.92 Cr, EPS ₹2.67. Borrowings cut 89.62% to ₹2.59 Cr. ROCE 7.10%.
Grovy India Q2 FY27 Results: Net Profit ₹2 Cr, Up 400.0% YoY
Grovy India Ltd reported revenue from operations of ₹26.9 Cr (+79.3% YoY) and net profit of ₹2 Cr (+400.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹2 Cr · +400.0% YoY
Grovy India Board Meeting Date
Grovy India Limited scheduled a board meeting for October 26, 2026, to consider and approve its unaudited financial results for the quarter ended September 30, 2026.
Grovy India Other Announcement
Grovy India Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026, in accordance with SEBI regulations.
Grovy India Other Announcement
Grovy India Ltd has submitted its quarterly shareholding pattern as per SEBI regulations. This is a routine periodic disclosure of shareholding data.
Other board meeting date announcements
All →Indowind Energy Board Meeting Date
Indowind Energy scheduled a board meeting on 5 Nov 2026 to approve Q1 FY27 unaudited results. The trading window remains closed until 48 hours post-approval.
Dhunseri Ventures Board Meeting Date
Dhunseri Ventures Ltd intimated that its Board will meet on 6 November 2026, inter alia to approve Q2 FY27 results. The trading window stays closed until 8 November 2026.
CESC Board Meeting Date
CESC Ltd scheduled its Board Meeting for 5 Nov 2026 to consider Q2/H1 FY27 unaudited results. No financial figures or decisions are reported in this advance intimation.
Genpharmasec Board Meeting Date
Genpharmasec Ltd will hold a Board meeting on 03 Nov 2026. Agenda includes proposing approval of Q2/H1 FY27 unaudited results.
Hexa Tradex Board Meeting Date
Hexa Tradex scheduled its board meeting for November 5, 2026, to approve Q2 FY27 unaudited financial results. Trading window closes until 48 hours post-disclosure.
Ampvolts Board Meeting Date
Ampvolts Ltd has scheduled its Board meeting for November 6, 2026, to approve unaudited Q2/H1 FY27 results. No financial figures are disclosed in this prior intimation.